
Mortality rates for ischemic heart disease in Asian American subpopulations were found to be more burdensome than previously reported, according to a Northwestern Medicine study published in JAMA Internal Medicine.

Jeremy Nathans, MD, PhD, the recipient of the 2022 Mechthild Esser Nemmers Prize in Medical Science, delivered a keynote lecture on the molecular mechanisms of visual systems.

More than 480 investigators, students, trainees and faculty presented scientific posters and abstracts at Feinberg’s 16th Annual Lewis Landsberg Research Day.

The first biologic drug to treat moderate-to-severe eczema in infants and children was highly effective in reducing symptoms, according to a recent study.

Therapeutically inhibiting a metabolic regulator in monocytes unexpectedly increased inflammatory signaling, revealing mechanisms that could inform new strategies to treat chronic inflammatory disorders, according to a recent study.

CRISPR pioneer and Nobel Laureate Jennifer Doudna, PhD is the recipient of the inaugural $250,000 Kimberly Prize in Biochemistry and Molecular Genetics.

A two-drug combination has been shown to improve patient response to treatment in relapsed or refractory acute myeloid leukemia.

Gen Zers and millennials are approximately two times more likely to be newly diagnosed with high blood pressure during pregnancy, reports a new Northwestern Medicine study.

Investigators have developed a new imaging technique that increases the detection and identification of proteoforms by four-fold when compared to current methods.

Northwestern Medicine investigators continue to study COVID-19, from comparing mortality rates between SARS-CoV-2 variants to examining the effectiveness of maternal vaccination in protecting infants and combating COVID-19 misinformation on social media.